Phase I and Pharmacokinetic Study of Gimatecan Given Orally Once a Week for 3 of 4 Weeks in Patients with Advanced Solid TumorsAndrew X. Zhu, Jeffrey G. Supko, Jeffrey W. Clark et al.|Clinical Cancer Research|2008Cited by 27
LPI-GPR55 promotes endothelial cell activation and inhibits autophagy through inducing LINC01235 expressionXiaoying He, Hongqin Wang|Annals of Medicine|2024Cited by 7